An analyst from Deutsche Bank maintained CVS Health Corp (NYSE: CVS) at 'hold' with a price target of $81.00 from a prior price target of $87.00. Prior to this rating, CVS Health Corp had...
CVS Health (CVS) asks corporate workers to help ease Covid shot demand crunch by completing shift at pharmacies each week - WSJ
CVS Health (CVS) declared a quarterly dividend of $0.605 per share, or $2.42 annualized.The dividend will be payable on November 1, 2023, to stockholders of record on October 20, 2023, with...
Walgreens Boots Alliance (NASDAQ: NASDAQ:WBA) and CVS Health (NYSE: NYSE:CVS), two leading pharmacy retailers, offer attractive yields to investors. However, the companies' differing...
CVS Health Corporation (CVS) has appointed Michael F. Mahoney, Chairman and CEO of Boston Scientific Corporation, a global medical technology leader, to serve on the Board of Directors (the...
Wednesday's top analyst upgrades and downgrades included Arm, Carnival, CVS Health, Deere, Dell Technologies, Intercontinental Exchange, Planet Fitness, Rackspace Technology, Royal Caribbean...
Investing.com -- U.S. were falling on Tuesday as investors await the start of the crucial two-day Federal Reserve meeting, which could set the tone for weeks to come. Here are some of the...
Investing.com -- Shares in CVS Health (NYSE:CVS) edged higher in early U.S. trading on Tuesday after analysts at Evercore ISI upgraded their rating of the healthcare group to outperform from...
Investing.com -- U.S. futures traded marginally higher Tuesday, as investors await the start of the crucial two-day Federal Reserve meeting, which could set the tone for weeks to come. Here...
Investing.com -- Here is your Pro Recap of the biggest analyst picks you may have missed since yesterday: an Overweight initiation for |Super Micro Computer, and upgrades for Dell, CVS,...
(Updated - September 19, 2023 5:31 AM EDT) Evercore ISI analyst upgraded CVS Health (NYSE:CVS) from In Line to Outperform with a price target of $83.00 (from $81.00).The analyst comments...
Wednesday's top analyst upgrades and downgrades included CVS Health, DataDog, Endeavor, Enphase Energy, Extreme Networks, GitLab, Nvidia, RTX, Splunk and United Parcel Service.
An analyst from Wolfe Research maintained CVS Health Corp (NYSE: CVS) at 'outperform' with a price target of $80.00. Prior to this rating, CVS Health Corp had 22 buy ratings, 6 hold...
Wolfe Research analysts upgraded CVS Health (NYSE:CVS) to Outperform from Peer Perform with a new $80 price target in a note Tuesday. Wolfe analysts told investors in a note that the...
Investing.com -- Here is your Pro Recap of the biggest analyst picks you may have missed since Friday: upgrades at |CVS Health, Brown Forman, Geron, and a buy initiation for...
Wolfe Research analyst upgraded CVS Health (NYSE:CVS) from Peerperform to Outperform with a price target of $80.00.The analyst comments "Our Review of Potential CVS LT Guidance Shifts...
Wolfe Research analyst reiterated a Peerperform rating on CVS Health (NYSE:CVS)The analyst comments "Combination of Cut Point Analysis and Company Commentary Indicates Large PPO Contract...
CVS Health (CVS) Climbs 2.7%Reason for the spike wasn't clearThe company is set to present tomorrow at Morgan Stanley
CVS Health Corp (NYSE: CVS) has launched Cordavis, a wholly-owned subsidiary, to work directly with manufacturers to commercialize and/or co-produce biosimilar products in the U.S....
CVS Health® (CVS) today announced that it has launched Cordavis, a wholly owned subsidiary that will work directly with manufacturers to commercialize and/or co-produce biosimilar products...
Tuesday's top analyst upgrades and downgrades included Applied Materials, Bill, Catalyst Pharmaceutical, CVS Health, Elastic, Hawaiian Electric Industries and Walmart.
Here is your Pro Recap of the biggest analyst cuts you may have missed since Friday: downgrades at |CVS Health, Medical Properties Trust, Napco Security Technologies, and...
Edward Jones has downgraded its outlook for CVS Health to Hold.
Investing.com -- Health care stocks were mixed on Friday after analysts downgraded Cigna and CVS Health citing concerns about competition in the pharmacy benefit manager business. Edward...
An analyst from Edward Jones downgraded CVS Health Corp (NYSE: CVS) from 'buy' to 'hold' . Prior to this rating, CVS Health Corp had 21 buy ratings, 7 hold ratings, and 0 sell ratings. For...
By Saeed Azhar and Amruta Khandekar NEW YORK (Reuters) - Wall Street's main indexes closed lower after choppy trading on Thursday as losses in healthcare stocks eclipsed gains in Cisco and...
Investing.com -- The Dow closed lower Thursday, pressured by a slide in Walmart and an ongoing surge in Treasury yields as fears grow that rate hikes will make a comeback later this...
CVS Health (NYSE:CVS) disclosed:CVS Health Corporation (“CVS Health,” the “Company,” “we” or “our”) understands that Blue Shield of California has announced today, as part of a new pharmacy...
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
